The KKR deal for Envision is expected to be publicized Monday, the Wall Street Journal reported Sunday.�
The move would come after Envision announced in October that it would consider "strategic alternatives" for its future, which is business terminology for a possible sale or other restructuring�moves.
Envision provides doctor-led medical services at its�261 surgery centers and one surgical hospital in 35 states.�
KKR and Envision representatives were not immediately available to comment Sunday afternoon.
KKR has done several health care deals recently, including 2017's acquisition of WebMD, an online provider of medical information.
Top 5 Medical Stocks To Buy For 2019: Iteris, Inc.(ITI)
Advisors' Opinion:- [By Max Byerly]
Iteris (NASDAQ:ITI) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a report released on Saturday.
Several other research analysts have also commented on the company. JMP Securities initiated coverage on Iteris in a research report on Thursday, January 25th. They issued an “outperform” rating and a $10.50 price objective on the stock. B. Riley set a $9.00 price objective on Iteris and gave the company a “buy” rating in a research report on Thursday, February 8th. Finally, Zacks Investment Research lowered Iteris from a “hold” rating to a “sell” rating in a research report on Wednesday, April 4th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Iteris has a consensus rating of “Buy” and a consensus price target of $8.75.
- [By Stephan Byrd]
iTicoin (CURRENCY:ITI) traded 21.2% higher against the U.S. dollar during the one day period ending at 20:00 PM Eastern on June 2nd. iTicoin has a total market capitalization of $543,370.00 and approximately $61.00 worth of iTicoin was traded on exchanges in the last 24 hours. In the last week, iTicoin has traded up 20.2% against the U.S. dollar. One iTicoin coin can currently be bought for approximately $16.98 or 0.00222465 BTC on major exchanges including BTC Trade UA, BTC-Alpha, Cryptopia and Livecoin.
- [By Shane Hupp]
B. Riley set a $9.00 price target on Iteris (NASDAQ:ITI) in a research report sent to investors on Wednesday morning. The brokerage currently has a buy rating on the technology company’s stock. B. Riley also issued estimates for Iteris’ Q4 2018 earnings at ($0.04) EPS, FY2018 earnings at ($0.08) EPS, Q1 2019 earnings at ($0.02) EPS, Q2 2019 earnings at ($0.05) EPS, Q3 2019 earnings at ($0.01) EPS, Q4 2019 earnings at ($0.04) EPS, FY2019 earnings at ($0.11) EPS, FY2020 earnings at $0.16 EPS and FY2021 earnings at $0.52 EPS.
- [By Shane Hupp]
Iteris (NASDAQ: ITI) and Napco Security Technologies (NASDAQ:NSSC) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.
- [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
- [By Stephan Byrd]
Iteris (NASDAQ: ITI) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.
Top 5 Medical Stocks To Buy For 2019: Cumberland Pharmaceuticals Inc.(CPIX)
Advisors' Opinion:- [By Max Byerly]
COPYRIGHT VIOLATION NOTICE: “Cumberland Pharmaceuticals (CPIX) Research Coverage Started at B. Riley” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/3364464/cumberland-pharmaceuticals-cpix-research-coverage-started-at-b-riley.html.
- [By Logan Wallace]
JW Asset Management LLC cut its stake in Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) by 32.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 178,942 shares of the specialty pharmaceutical company’s stock after selling 84,939 shares during the period. Cumberland Pharmaceuticals comprises about 1.2% of JW Asset Management LLC’s holdings, making the stock its 16th largest holding. JW Asset Management LLC owned about 1.14% of Cumberland Pharmaceuticals worth $1,195,000 as of its most recent filing with the Securities and Exchange Commission.
Top 5 Medical Stocks To Buy For 2019: Madrigal Pharmaceuticals, Inc. (MDGL)
Advisors' Opinion:- [By Shane Hupp]
Madrigal Pharmaceuticals (NASDAQ:MDGL)‘s stock had its “buy” rating restated by investment analysts at Cowen in a research note issued on Thursday.
- [By Lisa Levin]
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares shot up 132 percent to $251.6029 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
- [By George Budwell]
Shares of the clinical-stage biotech�Viking Therapeutics (NASDAQ:VKTX) are soaring this morning following positive mid-stage trial results for Madrigal Pharmaceuticals' (NASDAQ:MDGL) nonalcoholic�steatohepatitis (NASH) candidate�MGL-3196.
- [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks. Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday. Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days. Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension. China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86. J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings. Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory. Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48. Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results. The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash. Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
- [By Lisa Levin]
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares shot up 144 percent to $264.885 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
- [By Sean Williams]
Perhaps no company has received more interest in recent weeks than Madrigal Pharmaceuticals (NASDAQ:MDGL) which, might I add, has gained more than 1,800% over the trailing year.
Top 5 Medical Stocks To Buy For 2019: KeyCorp(KEY)
Advisors' Opinion:- [By Joseph Griffin]
KEY (CURRENCY:KEY) traded up 0.6% against the U.S. dollar during the one day period ending at 13:00 PM Eastern on July 1st. During the last week, KEY has traded up 7.6% against the U.S. dollar. One KEY token can now be bought for about $0.0063 or 0.00000099 BTC on popular exchanges. KEY has a market cap of $0.00 and approximately $284,702.00 worth of KEY was traded on exchanges in the last day.
- [By Max Byerly]
Get a free copy of the Zacks research report on KeyCorp (KEY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Teacher Retirement System of Texas lessened its position in KeyCorp (NYSE:KEY) by 19.2% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 237,965 shares of the financial services provider’s stock after selling 56,681 shares during the quarter. Teacher Retirement System of Texas’ holdings in KeyCorp were worth $4,652,000 at the end of the most recent quarter.
- [By ]
That said, I never completely abandoned the space. I remain long Citigroup (C) , I am flat KeyCorp (KEY) , having managed to maximize that trade earlier this year. Recently, your pal even reloaded his Goldman Sachs (GS) long after having trimmed that position appropriately. That, friends, is based on my belief that volatility will allow this legendary firm to reclaim its reputation. This one, I'll watch with great anticipation. They report on Tuesday, April 17. My trigger finger itches now.
- [By Money Morning Staff Reports]
KeyCorp (NYSE: KEY), the parent company of KeyBank, announced that it will hike its dividend by a whopping 42%. The announcement – a hike from $0.12 to $0.17 – is further proof that U.S. banks are much healthier. KEY also just hit the "Buy Zone" on the Money Morning Stock VQScore�� system.
- [By Stephan Byrd]
Gifford Fong Associates acquired a new stake in shares of KeyCorp (NYSE:KEY) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 30,000 shares of the financial services provider’s stock, valued at approximately $587,000.
Top 5 Medical Stocks To Buy For 2019: WGL Holdings Inc(WGL)
Advisors' Opinion:- [By Shane Hupp]
Franklin Resources Inc. purchased a new stake in shares of WGL Holdings Inc (NYSE:WGL) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 28,373 shares of the utilities provider’s stock, valued at approximately $2,374,000. Franklin Resources Inc. owned about 0.06% of WGL as of its most recent SEC filing.
- [By Stephan Byrd]
WGL Holdings Inc (NYSE:WGL)’s share price reached a new 52-week high during trading on Thursday . The stock traded as high as $88.75 and last traded at $88.72, with a volume of 377688 shares traded. The stock had previously closed at $88.56.
No comments:
Post a Comment